Marcos Vidal-Manrique

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Radboud University Medical Center(Current)

Radboud University Nijmegen

Marcos Vidal-Manrique is an author at Radboud University Medical Center specializing in oncology, polyunsaturated fatty acid metabolism, and fatty acid transport proteins.

ORCID

Publications per year

2022–2024

Publications

Fatty acid metabolism in aggressive B-cell lymphoma is inhibited by tetraspanin CD37

Rens Peeters, Jorge Cuenca‐Escalona, Esther A. Zaal et al. · Nature Communications · 2022 · 36 citations · Full text

Life Sciences, Biochemistry, Oncology +17

EP2/EP4 targeting prevents tumor-derived PGE2-mediated immunosuppression in cDC2s

Jorge Cuenca‐Escalona, Johanna Bödder, Beatriz Subtil et al. · Journal of Leukocyte Biology · 2024 · 11 citations · Full text

Life Sciences, Immunology, Oncology +17

Challenges in αCD38-chimeric antigen receptor (CAR)-expressing natural killer (NK) cell-based immunotherapy in multiple myeloma: Harnessing the CD38dim phenotype of cytokine-stimulated NK cells as a strategy to prevent fratricide

Maria Karvouni, Marcos Vidal-Manrique, Katharina H. Susek et al. · Cytotherapy · 2023 · 10 citations · Full text

Life Sciences, Cell Biology, Immunology +17

1–3 of 3